Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-28 · accession 0001415889-24-019020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | 2024-06-28 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $2.96 | +4,854 | 10.5K | +86% | +$14.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-28 | A | A | 4,854 | $2.96 | 10,487 | D | — | — | (F1) Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. |